Stuart E. Lind

6.9k total citations · 1 hit paper
76 papers, 5.7k citations indexed

About

Stuart E. Lind is a scholar working on Molecular Biology, Nutrition and Dietetics and Oncology. According to data from OpenAlex, Stuart E. Lind has authored 76 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Nutrition and Dietetics and 12 papers in Oncology. Recurrent topics in Stuart E. Lind's work include Cellular Mechanics and Interactions (7 papers), Trace Elements in Health (7 papers) and Blood properties and coagulation (7 papers). Stuart E. Lind is often cited by papers focused on Cellular Mechanics and Interactions (7 papers), Trace Elements in Health (7 papers) and Blood properties and coagulation (7 papers). Stuart E. Lind collaborates with scholars based in United States, China and France. Stuart E. Lind's co-authors include Paul A. Janmey, Thomas P. Stossel, Bolin Liu, Ann D. Thor, Susan M. Edgerton, Wei-Qun Ding, Zeying Fan, David B. Smith, Byron J. Good and Irina Alimova and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Biological Chemistry.

In The Last Decade

Stuart E. Lind

75 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nonmuscle Actin-Binding Proteins

1985 513 citations Thomas P. Stossel, Paul A. Janmey et al. profile →

Peers

Countries citing papers authored by Stuart E. Lind

Since Specialization

Citations

This map shows the geographic impact of Stuart E. Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart E. Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart E. Lind more than expected).

Fields of papers citing papers by Stuart E. Lind

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart E. Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart E. Lind. The network helps show where Stuart E. Lind may publish in the future.

Co-authorship network of co-authors of Stuart E. Lind

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart E. Lind. A scholar is included among the top collaborators of Stuart E. Lind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart E. Lind. Stuart E. Lind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of Rivaroxaban Exposure via Anti-Xa Levels During VTE Prophylaxis in Hospitalized Patients 2025 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), (unknown), Toby C. Trujillo, (unknown), Stuart E. Lind, (unknown), (unknown), Tyree H. Kiser	0
2	Phosphatidylserine is an overlooked mediator of COVID-19 thromboinflammation 2021 ·Heliyon ·Stuart E. Lind	14
3	Evaluation of intravenous direct thrombin inhibitor monitoring tests: Correlation with plasma concentrations and clinical outcomes in hospitalized patients 2019 ·Journal of Thrombosis and Thrombolysis ·(unknown), Stuart E. Lind, Sheila Fisher, Toby C. Trujillo, Michael F. Wempe, Tyree H. Kiser	25
4	Zinc Protoporphyrin Suppresses β-Catenin Protein Expression in Human Cancer Cells: The Potential Involvement of Lysosome-Mediated Degradation 2015 ·PLoS ONE ·Shuai Wang, Bethany N. Hannafon, Stuart E. Lind, Wei‐Qun Ding	11
5	Zinc protoporphyrin suppresses cancer cell viability through a heme oxygenase-1-independent mechanism: The involvement of the Wnt/β-catenin signaling pathway 2013 ·Biochemical Pharmacology ·Shuai Wang, (unknown), Bethany N. Hannafon, Stuart E. Lind, Wei-Qun Ding	25
6	Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers 2012 ·Cell Cycle ·Xin‐Sheng Deng, Shuiliang Wang, (unknown), Bolin Liu, Susan M. Edgerton, Stuart E. Lind, Reema S. Wahdan-Alaswad, Ann D. Thor	180
7	N-Acetylcysteine interacts with copper to generate hydrogen peroxide and selectively induce cancer cell death 2010 ·Cancer Letters ·Jie Zheng, (unknown), (unknown), Doris M. Benbrook, Marie H. Hanigan, Stuart E. Lind, (unknown)	48
8	Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro 2009 ·Cell Cycle ·Irina Alimova, Bolin Liu, Zeying Fan, Susan M. Edgerton, Thomas E. Dillon, Stuart E. Lind, Ann D. Thor	430
9	Copper Deficiency After Gastric Surgery: A Reason for Caution 2009 ·The American Journal of the Medical Sciences ·Călin I. Prodan, Sylvia S. Bottomley, Andrea S. Vincent, Linda D. Cowan, Beverley Greenwood–Van Meerveld, Neil R. Holland, Stuart E. Lind	28
10	Zinc-binding compounds induce cancer cell death via distinct modes of action 2008 ·Cancer Letters ·Wei-Qun Ding, Haijun Yu, Stuart E. Lind	57
11	Hypocupremia associated with prior vitamin B₁₂ deficiency 2006 ·American Journal of Hematology ·Călin I. Prodan, Sylvia S. Bottomley, Andrea S. Vincent, Linda D. Cowan, Neil R. Holland, Stuart E. Lind	6
12	Assessment of coagulation system activation using spot urine measurements 1999 ·Blood Coagulation & Fibrinolysis ·Stuart E. Lind, (unknown), (unknown), John R. Lindquist, Antoni A Piergies, Todd Rosen, Jens Schneider, (unknown), (unknown)	6
13	USE OF A MODIFIED ACTIVATED PARTIAL THROMBOPLASTIN TIME TO DETECT LUPUS ANTICOAGULANTS 1996 ·Thrombosis Research ·(unknown), (unknown), Stuart E. Lind	2
14	Transforming growth factor β regulation of migration in wounded rat intestinal epithelial monolayers 1993 ·Gastroenterology ·Carolina Ciacci, Stuart E. Lind, (unknown)	195
15	Patients' preferences for learning the results of mammographic examinations 1992 ·Breast Cancer Research and Treatment ·Stuart E. Lind, Daniel B. Kopans, Mary‐Jo DelVecchio Good	34
16	Finder's Fees for Research Subjects 1990 ·New England Journal of Medicine ·Stuart E. Lind	25
17	Apparent response of refractory post‐transfusion purpura to splenectomy 1989 ·American Journal of Hematology ·C. Casey Cunningham, Stuart E. Lind	9
18	Telling the diagnosis of cancer. 1989 ·Journal of Clinical Oncology ·Stuart E. Lind, (unknown), (unknown), Thomas J. Csordas, Byron J. Good	114
19	Depression of Gelsolin Levels and Detection of Gelsolin-Actin Complexes in Plasma of Patients with Acute Lung Injury 1988 ·American Review of Respiratory Disease ·Stuart E. Lind, David B. Smith, Paul A. Janmey, Thomas P. Stossel	88
20	Detection of acute inflammation with 111In-Labeled nonspecific polyclonal IgG 1988 ·Seminars in Nuclear Medicine ·(unknown), Robert H. Rubin, Ban An Khaw, Ronald J. Callahan, Robert J. Wilkinson, (unknown), Mark Nedelman, Stephen C. Dragotakes, (unknown), (unknown), Stuart E. Lind, H W Strauss	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact